Saturday, December 05, 2020 1:11:03 PM
Vaccines to be starting next year so continued increases in cases is expected for some time...
Many are concerned about taking vaccines.
Many still dont social distance or wear defensive/preventive masks, especially in the USA it seems, causing continued future infections.
World wide licensing for production through a Big Pharma seems the best way to distribute enough to all the places where it is needed.
Say 10% to 30% or more will want a pill with effective results compared to tough and/or expensive infusion courses or a semi effective (at best) drug like REM. JMHO.
The safety record implies that Ifenprodil can possibly be given as an outpatient medicine for the earlier cases not yet hospitalized. There is also a possible use for recovering patients with lung damage for the ARDS/IPF issues many suffer after basic recovery.
Lastly, CEO CM discussed the questions about a COVID 20-21 etc that current vaccines probably wont be effective against. There will be continued need for Treatments.
I feel Good about this investment for several strong reasons...GLTA...
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM